The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
Abstract Traditional epidemiological studies are susceptible to confounding factors. To clarify the impact of metabolic syndrome and its diagnostic components on hepatocellular carcinoma, we conducted a preliminary mendelian randomization analysis with metabolic syndrome and its diagnostic component...
Saved in:
| Main Authors: | Chendong Yuan, Xufeng Shu, Xiaoqiang Wang, Wenzheng Chen, Xin Li, Wenguang Pei, Xujie Su, Zhenzhen Hu, Zhigang Jie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-86317-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study
by: Zheng Wang, et al.
Published: (2025-01-01) -
Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk
by: Wei Shen, et al.
Published: (2025-07-01) -
Relationship between retinol metabolism and hepatocellular carcinoma: a comprehensive analysis of Mendelian randomization, prognostic characteristic and experiment
by: Fuqing Chen, et al.
Published: (2025-04-01) -
Mendelian randomization analysis of inflammatory biomarkers and hepatocellular carcinoma risk: genetic causality and single-cell transcriptomics
by: GuangXin Shao, et al.
Published: (2025-08-01) -
Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications
by: Longhui Xie, et al.
Published: (2025-04-01)